Practical Pathological Assessment of Residual Cancer Burden (RCB) After Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Invasive Breast Carcinoma: A Case Report.
- DOI
- 10.7759/cureus.117596
- Published
- 2026 Oct
- Container
- Cureus
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7759/cureus.117596,
title = {Practical Pathological Assessment of Residual Cancer Burden (RCB) After Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Invasive Breast Carcinoma: A Case Report.},
author = {Rathod G and R C and Pradeep I and Kondeti AK},
year = {2026},
journal = {Cureus},
doi = {10.7759/cureus.117596},
url = {https://doi.org/10.7759/cureus.117596}
}RIS
TY - JOUR TI - Practical Pathological Assessment of Residual Cancer Burden (RCB) After Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Invasive Breast Carcinoma: A Case Report. AU - Rathod G AU - R C AU - Pradeep I AU - Kondeti AK PY - 2026 JO - Cureus DO - 10.7759/cureus.117596 UR - https://doi.org/10.7759/cureus.117596 ER -
APA
G, R., C, R., I, P., & AK, K. (2026). Practical Pathological Assessment of Residual Cancer Burden (RCB) After Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Invasive Breast Carcinoma: A Case Report.. Cureus. https://doi.org/10.7759/cureus.117596
Source records
- pubmed · retrieved 2026-11-10T07:37:39.815Z
- europe-pmc · retrieved 2026-11-10T07:37:39.833Z